ArticleDiabetes2017

Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes.

Peter Willeit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.